Ryzumvi: pioneering advances in countering drug-induced mydriasis
Ayesha Azhar(Dow University of Health Sciences), Aymar Akilimali(Roslin Institute), Ashna Habib(Dow University of Health Sciences), Rumaisa Riaz(Dow University of Health Sciences), Afsheen Khan(Dow University of Health Sciences), Varsha Kumari(Dow University of Health Sciences)
Cited by 1
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29
Barriers Encountered Toward Pursuing a Neurosurgical Career: A Cross-Sectional Study Among Medical Students, Interns, and Junior Doctors in Africa
|World Neurosurgery|2022|26
The unmet need of organ transplantation in Africa
|International Journal of Surgery|2023|21